Shattuck Labs Inc (NAS:STTK)
$ 1.18 -0.06 (-4.84%) Market Cap: 56.32 Mil Enterprise Value: -42.34 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 45/100

Shattuck Labs Inc at Truist Securities Life Sciences Summit (May Series) Transcript

May 05, 2021 / 05:50PM GMT
Release Date Price: $32.76 (-6.91%)
Asthika Goonewardene
Truist Securities - Analyst

Welcome, everyone, to the next session. My name is Asthika Goonewardene, senior biotech analyst at Truist Securities. Great pleasure to have the team from Shattuck Labs on here now to discuss their exciting company. We have Taylor Schreiber, CEO and Co-Founder; and Andrew Neill, Chief Financial Officer, joining us here.

I will read out some quick disclosures. This call is arranged by Truist Securities Research for use by institutional investors and institutional clients as defined by FINRA. If you're not an institutional investor or issuer, please disconnect at this time. For required disclosures, please see our website at truistsecurities.com or our equity research library. Andrew why don't I hand it over to you to give us a little introduction to Shattuck Labs.

Andrew Neill
Shattuck Labs, Inc. - CFO

Sure. And, Asthika, can you see my slides properly?

Asthika Goonewardene;Andrew Neill
Truist Securities - Analyst

Yes, I can.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot